Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke Tablet for post-COVID-19 cough
ChiCTR2300068877Phase 4Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Feb 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cough comparing Lianhua Qingke Tablet Group with Placebo control group (2 arms). Primary endpoint: Time of cough disappearance within 14 days. Started Feb 2023; status: recruiting.
02
Drugs
Lianhua Qingke
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR2300068877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068877.